These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12615850

  • 1. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G, Rodloff AC.
    J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
    [Abstract] [Full Text] [Related]

  • 2. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D.
    Clin Microbiol Infect; 2001 Mar; 7 Suppl 3():2-10. PubMed ID: 11523558
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationships of ketolides vs. macrolides.
    Douthwaite S.
    Clin Microbiol Infect; 2001 Mar; 7 Suppl 3():11-7. PubMed ID: 11523556
    [Abstract] [Full Text] [Related]

  • 4. The ketolides: a critical review.
    Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ.
    Drugs; 2002 Mar; 62(12):1771-804. PubMed ID: 12149046
    [Abstract] [Full Text] [Related]

  • 5. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA.
    Liu M, Douthwaite S.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1629-33. PubMed ID: 12019067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Telithromycin: an oral ketolide for respiratory infections.
    Bearden DT, Neuhauser MM, Garey KW.
    Pharmacotherapy; 2001 Oct; 21(10):1204-22. PubMed ID: 11601667
    [Abstract] [Full Text] [Related]

  • 8. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.
    Yassin HM, Dever LL.
    Expert Opin Investig Drugs; 2001 Feb; 10(2):353-67. PubMed ID: 11178347
    [Abstract] [Full Text] [Related]

  • 9. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J.
    Int J Clin Pract; 2003 Feb; 57(6):519-29. PubMed ID: 12918892
    [Abstract] [Full Text] [Related]

  • 10. Ketolides in the treatment of respiratory infections.
    Zhanel GG, Hoban DJ.
    Expert Opin Pharmacother; 2002 Mar; 3(3):277-97. PubMed ID: 11866679
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z, Tunçkanat F, Ozçakir O, Ercis S.
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [Abstract] [Full Text] [Related]

  • 13. Will resistance to ketolides develop in Streptococcus pneumoniae?
    Leclercq R.
    J Infect; 2002 Feb; 44 Suppl A():11-6. PubMed ID: 12150490
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J, Kataja J, Seppälä H, Huovinen P.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [Abstract] [Full Text] [Related]

  • 15. In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.
    Bonnefoy A, Guitton M, Delachaume C, Le Priol P, Girard AM.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1688-92. PubMed ID: 11353612
    [Abstract] [Full Text] [Related]

  • 16. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
    Lonks JR, Goldmann DA.
    Clin Infect Dis; 2005 Jun 01; 40(11):1657-64. PubMed ID: 15889365
    [Abstract] [Full Text] [Related]

  • 17. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
    Douthwaite S, Champney WS.
    J Antimicrob Chemother; 2001 Sep 01; 48 Suppl T1():1-8. PubMed ID: 11566971
    [Abstract] [Full Text] [Related]

  • 18. Telithromycin: the first of the ketolides.
    Shain CS, Amsden GW.
    Ann Pharmacother; 2002 Mar 01; 36(3):452-64. PubMed ID: 11895060
    [Abstract] [Full Text] [Related]

  • 19. Ketolides-telithromycin, an example of a new class of antibacterial agents.
    Bryskier A.
    Clin Microbiol Infect; 2000 Dec 01; 6(12):661-9. PubMed ID: 11284926
    [Abstract] [Full Text] [Related]

  • 20. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
    Zhanel GG, Hisanaga T, Nichol K, Wierzbowski A, Hoban DJ.
    Expert Opin Emerg Drugs; 2003 Nov 01; 8(2):297-321. PubMed ID: 14661991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.